The impact of PBRM1 mutations on OS did not reach statistical significance in any of the 4 cancer types, but the numerical trend of poor OS (HR >1) was observed in the univariable analysis.
← all excerpts
Comprehensive analyses of <i>PBRM1</i> in multiple cancer types and its association with clinical response to immunotherapy and immune infiltrates.
1
—
—